Xingyao He

527 total citations
9 papers, 300 citations indexed

About

Xingyao He is a scholar working on Molecular Biology, Genetics and Biomaterials. According to data from OpenAlex, Xingyao He has authored 9 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Genetics and 2 papers in Biomaterials. Recurrent topics in Xingyao He's work include Glioma Diagnosis and Treatment (5 papers), Chromatin Remodeling and Cancer (3 papers) and Protein Degradation and Inhibitors (3 papers). Xingyao He is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Chromatin Remodeling and Cancer (3 papers) and Protein Degradation and Inhibitors (3 papers). Xingyao He collaborates with scholars based in United States, Japan and Switzerland. Xingyao He's co-authors include Rintaro Hashizume, Nundia Louis, Susan K. Murphy, Zhiqing Huang, Carole Grenier, Oren J. Becher, Guo Hu, Roger E. McLendon, Francisco J. Cordero and Lihua Zou and has published in prestigious journals such as Nature Medicine, Journal of neurosurgery and Oncotarget.

In The Last Decade

Xingyao He

9 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xingyao He United States	6	223	99	50	42	30	9	300
Elizabeth Wadhwa United States	3	185 0.8×	145 1.5×	45 0.9×	45 1.1×	23 0.8×	5	296
Wendy J. Ingram Australia	7	267 1.2×	61 0.6×	41 0.8×	62 1.5×	24 0.8×	10	346
Alexandra Garancher United States	8	260 1.2×	103 1.0×	76 1.5×	76 1.8×	22 0.7×	11	323
Angelica Castano United States	3	180 0.8×	49 0.5×	76 1.5×	53 1.3×	19 0.6×	6	263
Susan T. Ragsdale United States	6	209 0.9×	123 1.2×	65 1.3×	63 1.5×	47 1.6×	7	322
Carmela Dantas-Barbosa France	9	159 0.7×	124 1.3×	57 1.1×	49 1.2×	30 1.0×	12	265
Sara Haddock United States	6	190 0.9×	93 0.9×	78 1.6×	50 1.2×	71 2.4×	7	298
Daisuke Kawauchi Japan	12	199 0.9×	152 1.5×	65 1.3×	68 1.6×	50 1.7×	29	375
Lee H. Chen United States	9	234 1.0×	92 0.9×	92 1.8×	53 1.3×	16 0.5×	12	350
Laura A. Genovesi Australia	12	287 1.3×	112 1.1×	111 2.2×	59 1.4×	30 1.0×	15	439

Countries citing papers authored by Xingyao He

Since Specialization

Citations

This map shows the geographic impact of Xingyao He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingyao He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingyao He more than expected).

Fields of papers citing papers by Xingyao He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingyao He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingyao He. The network helps show where Xingyao He may publish in the future.

Co-authorship network of co-authors of Xingyao He

This figure shows the co-authorship network connecting the top 25 collaborators of Xingyao He. A scholar is included among the top collaborators of Xingyao He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingyao He. Xingyao He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Ishi, Yukitomo, Ali Zhang, Takahiro Sasaki, et al.. (2022). Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors. Molecular Cancer Therapeutics. 21(5). 715–726. 20 indexed citations

2.

Sasaki, Takahiro, Jun Watanabe, Xingyao He, et al.. (2022). Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma. Journal of neurosurgery. 138(6). 1570–1579. 7 indexed citations

3.

Zhang, Ali, Andrea Piunti, Patrick A. Ozark, et al.. (2019). ATRT-02. THERAPEUTIC TARGETING OF EZH2 AND BET BRD4 IN AT/RT. Neuro-Oncology. 21(Supplement_2). ii63–ii63. 1 indexed citations

4.

Wang, Lu, Zibo Zhao, Patrick A. Ozark, et al.. (2018). Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. Nature Medicine. 24(6). 758–769. 121 indexed citations

5.

He, Xingyao, Nundia Louis, Hiroaki Katagi, et al.. (2018). DIPG-33. NEW THERAPEUTIC APPROACH FOR BRAINSTEM GLIOMA: INTRANASAL DELIVERY OF NANOLIPOSOMAL SN-38. Neuro-Oncology. 20(suppl_2). i55–i55. 1 indexed citations

6.

Cordero, Francisco J., Zhiqing Huang, Carole Grenier, et al.. (2017). Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG. Molecular Cancer Research. 15(9). 1243–1254. 97 indexed citations

7.

Louis, Nundia, Sharon Liu, Xingyao He, et al.. (2017). New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model. Journal of Neuro-Oncology. 136(3). 475–484. 24 indexed citations

8.

Piunti, Andrea, Marc A. Morgan, Elizabeth T. Bartom, et al.. (2017). PDTM-28. TARGETED INHIBITION OF EZH2 AND BET BROMODOMAIN PROTEINS FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMAS. Neuro-Oncology. 19(suppl_6). vi196–vi196. 2 indexed citations

9.

Sredni, Simone Treiger, Rintaro Hashizume, Xingyao He, et al.. (2017). Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma. Oncotarget. 8(67). 111190–111212. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact